Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapy
- Creator: Wong-Brown, Michelle W. , van der Westhuizen, Andre , Bowden, Nikola A.
- Resource Type: journal article
- Date: 2022
Biomarkers of platinum resistance in ovarian cancer: What can we use to improve treatment
- Creator: Van Zyl, Belinda , Tang, Denise , Bowden, Nikola A.
- Resource Type: journal article
- Date: 2018
Sequential decitabine and carboplatin treatment increases the DNA repair protein XPC, increases apoptosis and decreases proliferation in melanoma
- Creator: Budden, Timothy , van der Westhuizen, Andre , Bowden, Nikola A.
- Resource Type: journal article
- Date: 2018
The role of nucleotide excision repair in melanoma development and platinum chemotherapy resistance
- Creator: Budden, Timothy
- Resource Type: thesis
- Date: 2017
Nucleotide excision repair: why is it not used to predict response to platinum-based chemotherapy?
- Creator: Bowden, Nikola A.
- Resource Type: journal article
- Date: 2014
Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients
- Creator: Wagner, U. , Marth, C. , Gebski, V. , Lauraine, E. P. , Largillier, R. , Kaern, J. , Brown, C. , Heywood, M. , Bonaventura, T. , Vergote, I. , Piccirillo, M. C. , Fossati, R.
- Resource Type: journal article
- Date: 2012